BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11756230)

  • 1. Occupational exposure to organic solvents and K-ras mutations in exocrine pancreatic cancer.
    Alguacil J; Porta M; Malats N; Kauppinen T; Kogevinas M; Benavides FG; Partanen T; Carrato A;
    Carcinogenesis; 2002 Jan; 23(1):101-6. PubMed ID: 11756230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occupational exposure to dyes, metals, polycyclic aromatic hydrocarbons and other agents and K-ras activation in human exocrine pancreatic cancer.
    Alguacil J; Porta M; Kauppinen T; Malats N; Kogevinas M; Carrato A;
    Int J Cancer; 2003 Nov; 107(4):635-41. PubMed ID: 14520703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum concentrations of organochlorine compounds and K-ras mutations in exocrine pancreatic cancer. PANKRAS II Study Group.
    Porta M; Malats N; Jariod M; Grimalt JO; Rifà J; Carrato A; Guarner L; Salas A; Santiago-Silva M; Corominas JM; Andreu M; Real FX
    Lancet; 1999 Dec 18-25; 354(9196):2125-9. PubMed ID: 10609819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toenail concentrations of trace elements and occupational history in pancreatic cancer.
    Camargo J; Pumarega JA; Alguacil J; Sanz-Gallén P; Gasull M; Delclos GL; Amaral AFS; Porta M
    Environ Int; 2019 Jun; 127():216-225. PubMed ID: 30928845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occupational exposures and risk of pancreatic cancer.
    Santibañez M; Vioque J; Alguacil J; de la Hera MG; Moreno-Osset E; Carrato A; Porta M; Kauppinen T
    Eur J Epidemiol; 2010 Oct; 25(10):721-30. PubMed ID: 20640489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occupational solvent exposure and risk of meningioma: results from the INTEROCC multicentre case-control study.
    McLean D; Fleming S; Turner MC; Kincl L; Richardson L; Benke G; Schlehofer B; Schlaefer K; Parent ME; Hours M; Krewski D; van Tongeren M; Sadetzki S; Siemiatycki J; Cardis E
    Occup Environ Med; 2014 Apr; 71(4):253-8. PubMed ID: 24474387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lifetime history of tobacco consumption and K-ras mutations in exocrine pancreatic cancer.
    Crous-Bou M; Porta M; López T; Jariod M; Malats N; Alguacil J; Morales E; Fernandez E; Corominas JM; Carrato A; Guarner L; Real FX;
    Pancreas; 2007 Aug; 35(2):135-41. PubMed ID: 17632319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between coffee drinking and K-ras mutations in exocrine pancreatic cancer. PANKRAS II Study Group.
    Porta M; Malats N; Guarner L; Carrato A; Rifà J; Salas A; Corominas JM; Andreu M; Real FX
    J Epidemiol Community Health; 1999 Nov; 53(11):702-9. PubMed ID: 10656099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Food and nutrient intakes and K-ras mutations in exocrine pancreatic cancer.
    Morales E; Porta M; Vioque J; López T; Mendez MA; Pumarega J; Malats N; Crous-Bou M; Ngo J; Rifà J; Carrato A; Guarner L; Corominas JM; Real FX;
    J Epidemiol Community Health; 2007 Jul; 61(7):641-9. PubMed ID: 17568059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of K-ras codon 12 and 13 mutations found in pancreatic adenocarcinoma of 30 Chinese patients by microdissection, PCR and direct sequencing.
    Wei S; Liang Z; Gao J; Wu S; Zhu H; Liu H; Liu T
    J Gastroenterol Hepatol; 2005 Jan; 20(1):67-72. PubMed ID: 15610449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of K-ras gene mutations in DNA extracted from the plasma of patients with pancreatic cancer].
    Feng D; Han T; Jiang Y; Yuan Z; Wang X; Jiang Z; Zhang S
    Zhonghua Wai Ke Za Zhi; 2000 Oct; 38(10):767-70. PubMed ID: 11832160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical validity of detecting K-ras mutations for the diagnosis of exocrine pancreatic cancer: a prospective study in a clinically-relevant spectrum of patients.
    Parker LA; Porta M; Lumbreras B; López T; Guarner L; Hernández-Aguado I; Carrato A; Corominas JM; Rifà J; Fernandez E; Alguacil J; Malats N; Real FX
    Eur J Epidemiol; 2011 Mar; 26(3):229-36. PubMed ID: 21298467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sporadic and Thorotrast-induced angiosarcomas of the liver manifest frequent and multiple point mutations in K-ras-2.
    Przygodzki RM; Finkelstein SD; Keohavong P; Zhu D; Bakker A; Swalsky PA; Soini Y; Ishak KG; Bennett WP
    Lab Invest; 1997 Jan; 76(1):153-9. PubMed ID: 9010458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of pancreatic cancer and occupational exposures in Spain. PANKRAS II Study Group.
    Alguacil J; Kauppinen T; Porta M; Partanen T; Malats N; Kogevinas M; Benavides FG; Obiols J; Bernal F; Rifà J; Carrato A
    Ann Occup Hyg; 2000 Aug; 44(5):391-403. PubMed ID: 10930502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. K-ras and p53 in pancreatic cancer: association with medical history, histopathology, and environmental exposures in a population-based study.
    Slebos RJ; Hoppin JA; Tolbert PE; Holly EA; Brock JW; Zhang RH; Bracci PM; Foley J; Stockton P; McGregor LM; Flake GP; Taylor JA
    Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1223-32. PubMed ID: 11097231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. K-ras mutations in human adenocarcinoma of the lung: association with smoking and occupational exposure to asbestos.
    Husgafvel-Pursiainen K; Hackman P; Ridanpää M; Anttila S; Karjalainen A; Partanen T; Taikina-Aho O; Heikkilä L; Vainio H
    Int J Cancer; 1993 Jan; 53(2):250-6. PubMed ID: 8425762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlorinated hydrocarbon solvents and biliary-pancreatic cancer: report of three cases.
    Zarchy TM
    Am J Ind Med; 1996 Sep; 30(3):341-2. PubMed ID: 8876803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique K-ras mutational pattern in pancreatic adenocarcinoma from Taiwanese patients.
    Wang JY; Lian ST; Chen YF; Yang YC; Chen LT; Lee KT; Huang TJ; Lin SR
    Cancer Lett; 2002 Jun; 180(2):153-8. PubMed ID: 12175546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ki-ras mutations in exocrine pancreatic cancer: association with clinico-pathological characteristics and with tobacco and alcohol consumption. PANK-ras I Project Investigators.
    Malats N; Porta M; Corominas JM; Piñol JL; Rifà J; Real FX
    Int J Cancer; 1997 Mar; 70(6):661-7. PubMed ID: 9096646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ras gene mutations in patients with acute myeloid leukaemia and exposure to chemical agents.
    Barletta E; Gorini G; Vineis P; Miligi L; Davico L; Mugnai G; Ciolli S; Leoni F; Bertini M; Matullo G; Costantini AS
    Carcinogenesis; 2004 May; 25(5):749-55. PubMed ID: 14688017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.